Turning Point Brands may offer stock and debt
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Turning Point Brands, Inc. filed an automatic shelf registration covering common stock, preferred stock, depositary shares, warrants, units and debt securities. The company may offer these securities from time to time after the registration statement becomes effective, separately or in combinations.
Each offering’s prospectus supplement will provide its specific securities, amounts, prices and terms. Unless a supplement provides otherwise, net proceeds will be used for general corporate purposes, including working capital, repayment of indebtedness, acquisitions and other business purposes.
Filing Explained
The board can issue authorized common shares without a shareholder vote, and holders have no preemptive right to buy them.
No specific security sale is described in this filing; as of
Common holders have no preemptive rights to subscribe for securities, so issuing additional common shares would reduce existing holders’ percentage ownership absent offsetting changes.
The company also had 40,000,000 authorized preferred shares, none outstanding as of
Key Figures
Key Terms
automatic shelf regulatory
well-known seasoned issuer regulatory
at-the-market offerings financial
book-entry debt security financial
defeasance financial
liquidation preference financial
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What securities can TPB offer under its shelf registration?
AI-generated analysis. How Rhea-AI works. Not financial advice.
TABLE OF CONTENTS
Delaware (State or other jurisdiction of incorporation or organization) | 20-0709285 (I.R.S. Employer Identification No.) | ||
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||
Emerging growth company | ☐ | ||||||||
TABLE OF CONTENTS

TABLE OF CONTENTS
Page | |||
ABOUT THIS PROSPECTUS | ii | ||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | iii | ||
WHERE YOU CAN FIND ADDITIONAL INFORMATION | vi | ||
INCORPORATION BY REFERENCE | vi | ||
TURNING POINT BRANDS | 1 | ||
RISK FACTORS | 2 | ||
USE OF PROCEEDS | 3 | ||
DESCRIPTION OF CAPITAL STOCK | 4 | ||
DESCRIPTION OF DEPOSITARY SHARES | 8 | ||
DESCRIPTION OF WARRANTS | 11 | ||
DESCRIPTION OF UNITS | 12 | ||
DESCRIPTION OF DEBT SECURITIES | 13 | ||
PLAN OF DISTRIBUTION | 20 | ||
LEGAL MATTERS | 23 | ||
EXPERTS | 23 | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
• | declining sales of tobacco products and expected continuing decline of sales in the tobacco industry overall; |
• | our dependence on a small number of third-party suppliers and producers; |
• | the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost; |
• | the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted; |
• | failure to maintain consumer brand recognition and loyalty of our customers and in anticipating and responding to changes in consumer preferences and purchase behavior; |
• | our reliance on relationships with several large retailers and national chains for distribution of our products; |
• | intense competition and our ability to compete effectively; |
• | competition from illicit sources and the damage caused by illicit products to our brand equity; |
• | contamination of our tobacco supply or products; |
• | uncertainty and continued evolution of the markets for our products; |
• | recalls of our products; |
• | difficulties or liabilities arising from investments in businesses; |
• | substantial and increasing regulation and changes in the U.S. Food & Drug Administration (“FDA”) enforcement priorities; |
• | regulation or marketing denials of our products by the FDA, which has broad regulatory powers; |
TABLE OF CONTENTS
• | many of our products contain nicotine, which is considered to be a highly addictive substance; |
• | requirement to maintain compliance with master settlement agreement escrow account; |
• | possible significant increases in federal, state and local municipal tobacco- and nicotine-related taxes; |
• | our products are marketed pursuant to a policy of FDA enforcement priorities which could change, and our products could become subject to increased regulatory burdens by the FDA; |
• | sensitivity of end-customers to increased sales taxes and economic conditions, including as a result of inflation and other declines in purchasing power; |
• | possible increasing international control and regulation; |
• | failure to comply with environmental, health and safety regulations; |
• | imposition of significant tariffs on imports into the U.S.; |
• | the scientific community’s lack of information regarding the long-term health effects of certain substances contained in some of our products; |
• | significant product liability litigation; |
• | our amount of indebtedness; |
• | our credit rating and ability to access well-functioning capital markets; |
• | the terms of our indebtedness, which may restrict our current and future operations; |
• | our ability to establish and maintain effective internal controls over financial reporting; |
• | our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition bids or merger proposals, which may adversely affect the market price of our common stock; |
• | our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors (as defined in our Certificate of Incorporation). These restrictions may affect the liquidity of our common stock and may result in Restricted Investors being required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution rights; |
• | future sales of our common stock in the public market including through our “at the market offering” program could reduce our stock price, and any additional capital raised by us through the sale of equity or convertible securities may dilute your ownership in us; |
• | we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock; |
• | our business may be damaged by events outside of our or our suppliers’ control, such as the impact of epidemics or pandemics, political upheavals, or natural disasters; |
• | adverse impact of climate change and legal and regulatory requirements related to climate change and environmental sustainability; |
• | our reliance on information technology; |
• | cybersecurity and privacy breaches, including due to artificial intelligence; |
• | failure to manage our growth; |
• | failure to successfully identify, negotiate and complete suitable acquisition opportunities, integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions; |
TABLE OF CONTENTS
• | fluctuations in our results; |
• | exchange rate fluctuations; |
• | adverse U.S. and global economic conditions; |
• | departure of key management personnel or our inability to attract and retain talent; |
• | infringement on or misappropriation of our intellectual property; |
• | third-party claims that we infringe on their intellectual property; and |
• | impairment of intangible assets, including trademarks and goodwill. |
TABLE OF CONTENTS
• | Our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on March 2, 2026 (including the portions of our proxy statement for our 2026 annual meeting of the stockholders incorporated by reference therein); |
• | Our Quarterly Reports on Form 10-Q for the quarterly period ended March 31, 2026 filed with the SEC on May 8, 2026, the quarterly period ended June 30, 2026 filed with the SEC on August 4, 2026 and the quarterly period ended September 30, 2026 filed with the SEC on November 9, 2026; |
• | Our Current Report on Form 8-K filed with the SEC on May 5, 2026; |
• | The section entitled “Description of Registrant’s Securities to be Registered” contained in our Registration Statement on Form 8-A, filed pursuant to Section 12(b) of the Exchange Act, on May 4, 2016 and any amendment or report filed with the SEC for the purpose of updating the description, including Exhibit 4.2 to our Annual Report on Form 10-K. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | limits ownership of our common stock by any Restricted Investor to 14.9% of outstanding common stock and shares convertible or exchangeable therefor (including our non-voting common stock) (the “Permitted Percentage”); |
TABLE OF CONTENTS
• | provides that any issuance or transfer of shares in excess of the Permitted Percentage to any Restricted Investor will be ineffective and that neither we nor our transfer agent will register such purported issuance or transfer of shares or be required to recognize the purported transferee or owner as our stockholder for any purpose whatsoever except to exercise our remedies thereunder; |
• | permits withholding of dividends and suspends voting rights with respect to any shares held by any Restricted Investor that exceed the Permitted Percentage; |
• | permits us to require submission of such documentary and other evidence of status to aid determination of the percentage ownership of our capital stock by such holder; |
• | permits our board of directors to authorize us to redeem any shares held by any Restricted Investor that exceeds the Permitted Percentage; and |
• | permits our board of directors to make such determinations to ascertain ownership and implement such measures as reasonably may be necessary. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | all outstanding depositary shares have been redeemed; or |
• | there has been a final distribution of the preferred stock in connection with our dissolution and such distribution has been made to all the holders of depositary shares. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the title of warrants; |
• | the aggregate number of warrants offered; |
• | the price or prices at which the warrants will be issued; |
• | the currency or currencies, including composite currencies, in which the prices of the warrants may be payable; |
• | the designation, number and terms of the common stock, preferred stock or other securities (including debt securities) or rights, including rights to receive; |
• | payment in cash or securities based on the value, rate or price of one or more specified commodities, currencies or indices, purchasable; |
• | upon exercise of the warrants and procedures by which those numbers may be adjusted; |
• | the dates or periods during which the warrants are exercisable; |
• | the designation and terms of any securities with which the warrants are issued as a unit; |
• | if the warrants are issued as a unit with another security, the date on and after which the warrants and the other security will be separately transferable; |
• | if the exercise price is not payable in U.S. dollars, the foreign currency, currency unit or composite currency in which the exercise price is denominated; |
• | any minimum or maximum amount of warrants that may be exercised at any one time; |
• | any terms relating to the modification of the warrants; and |
• | any other terms of the warrants, including terms, procedures and limitations relating to the transferability, exchange, exercise or redemption of the warrants. \ |
• | vote, consent or receive dividends or interest; |
• | receive notice as stockholders with respect to any meeting of stockholders for the election of our directors or any other matter; or |
• | exercise any rights as stockholders of TPB. |
TABLE OF CONTENTS
• | the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances the securities comprising the units may be held or transferred separately; |
• | a description of the terms of any unit agreement governing the units; |
• | a description of the provisions for the payment, settlement, transfer or exchange of the units; and |
• | whether the units if issued as a separate security will be issued in fully registered or global form. |
TABLE OF CONTENTS
• | the title and ranking of the debt securities (including the terms of subordination provisions, if any); |
• | the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt securities; |
• | any limit on the aggregate principal amount of the debt securities; |
• | the date or dates on which the principal of the securities of the series is payable; |
• | the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates (including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates from which interest will accrue, the date or dates on which accrual of interest will commence and be payable and any regular record date for the interest payable on any interest payment date; |
• | the place or places where principal of, and interest, if any, on the debt securities will be payable (and the method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered; |
TABLE OF CONTENTS
• | the period or periods within which, the price or prices at which and the terms and conditions upon which we may redeem the debt securities; |
• | any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or otherwise or analogous provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which and in the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation; |
• | the dates on which and the price or prices at which we will repurchase debt securities at the option of the holders of debt securities and other detailed terms and provisions of these repurchase obligations; |
• | the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof; |
• | whether the debt securities will be issued in the form of certificated debt securities or global debt securities; |
• | the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other than the principal amount; |
• | the currency of denomination of the debt securities, which may be United States Dollars or any foreign currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency; |
• | the designation of the currency, currencies or currency units in which payment of principal of, premium, if any, and interest on the debt securities will be made; |
• | if payments of principal of, premium, if any, or interest on the debt securities will be made in one or more currencies or currency units other than those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined; |
• | the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; |
• | provisions relating to any security provided for the debt securities; |
• | any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities; |
• | any addition to, deletion of or change in the covenants set forth in the indenture with respect to the debt securities; |
• | any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to the debt securities; |
• | the provisions, if any, relating to conversion or exchange of any debt securities of such series, including if applicable, the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory, the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or exchange; |
• | any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as it applies to that series, including any terms that may be required under applicable law or regulations or advisable in connection with the marketing of the securities; and |
• | whether any of TPB’s direct or indirect subsidiaries will guarantee the debt securities of that series, including the terms of subordination, if any of such guarantees. (Section 2.2) |
TABLE OF CONTENTS
• | we are the surviving corporation or the successor person (if other than TPB) is a corporation, partnership, trust or other entity organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture; and |
• | immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing. |
TABLE OF CONTENTS
• | default in the payment of any interest upon any debt security of that series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the 30-day period); |
• | default in the payment of principal of any security of that series at its maturity and such default continues for a period of 10 days; |
• | default in the performance or breach of any other covenant or warranty by us in the indenture (other than a covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days after we receive written notice from the trustee or we and the trustee receive written notice from the holders of not less than 25% in principal amount of the outstanding debt securities of that series as provided in the indenture; |
• | certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of TPB; and |
• | any other Event of Default provided with respect to debt securities of that series that is described in the applicable prospectus supplement. (Section 6.1) |
TABLE OF CONTENTS
• | that holder has previously given to the trustee written notice of a continuing Event of Default with respect to debt securities of that series; and |
• | the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made written request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. (Section 6.7) |
• | to cure any ambiguity, defect or inconsistency; |
• | to comply with covenants in the indenture described above under the heading “Consolidation, Merger and Sale of Assets”; |
• | to provide for uncertificated securities in addition to or in place of certificated securities; |
• | to add guarantees with respect to debt securities of any series or secure debt securities of any series; |
• | to surrender any of our rights or powers under the indenture; |
• | to add covenants or events of default for the benefit of the holders of debt securities of any series; |
• | to comply with the applicable procedures of the applicable depositary; |
• | to make any change that does not adversely affect the rights of any holder of debt securities; |
• | to provide for the issuance of and establish the form and terms and conditions of debt securities of any series as permitted by the indenture; |
• | to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee; or |
• | to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture Act. (Section 9.1) |
TABLE OF CONTENTS
• | reduce the principal amount of debt securities whose holders must consent to an amendment, supplement or waiver; |
• | reduce the rate of or extend the time for payment of interest (including default interest) on any debt security; |
• | reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities; |
• | reduce the principal amount of discount securities payable upon acceleration of maturity; |
• | waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such acceleration); |
• | make the principal of or premium or interest on any debt security payable in a currency other than that stated in the debt security; |
• | make any change to certain provisions of the indenture relating to, among other things, the right of holders of debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit for the enforcement of any such payment and to waivers or amendments; or |
• | waive a redemption payment with respect to any debt security. (Section 9.3) |
TABLE OF CONTENTS
• | we may omit to comply with the covenant described under the heading “Consolidation, Merger and Sale of Assets” and certain other covenants set forth in the indenture, as well as any additional covenants which may be set forth in the applicable prospectus supplement; and |
• | any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to the debt securities of that series (“covenant defeasance”). |
• | The conditions include: |
• | depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal of, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and such debt securities; and |
• | delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred. (Section 8.4) |
TABLE OF CONTENTS
• | to or through underwriters, brokers or dealers; |
• | directly to one or more purchasers; |
• | through agents; |
• | “at the market offerings” to or through market makers or into an existing market for the securities; |
• | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
• | block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | privately negotiated transactions; |
• | short sales (including short sales “against the box”); |
• | through the writing or settlement of standardized or over-the-counter options or other hedging or derivative transactions, whether through an options exchange or otherwise; |
• | by pledge to secure debts and other obligations; |
• | in other ways not involving market makers or established trading markets, including direct sales to purchasers or sales effected through agents; |
• | a combination of any such methods of sale; and |
• | any other method permitted pursuant to applicable law and described in an applicable prospectus supplement. |
• | the name or names of any underwriters, dealers or agents and the amounts of securities underwritten or purchased by each of them; and |
• | the public offering price of the securities and the proceeds to us, and any discounts, commissions or concessions allowed or reallowed or paid to dealers. |
• | at a fixed price or prices, which may be changed from time to time; |
• | at market prices prevailing at the time of sale; |
• | at prices relating to the prevailing market prices; or |
• | at negotiated prices. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Item 14. | Other Expenses of Issuance and Distribution. |
SEC Registration Fee | $ (1)(2) | ||
FINRA Filing Fee | $(2) | ||
Legal Fees and Expenses | $(2) | ||
Accounting Fees and Expenses | $(2) | ||
Indenture Trustees’ Fees and Expenses | $(2) | ||
Transfer Agent Fees and Expenses | $(2) | ||
Blue Sky Fees and Expenses | $(2) | ||
Printing and Miscellaneous Expenses | $(2) | ||
(1) | Pursuant to Rules 456(b) and 457(r) under the Securities Act, the registration fee will be paid at the time of any particular offering of securities under this registration statement. |
(2) | The amount of these fees and expenses is not currently determinable. Estimates of the fees and expenses in connection with the sale and distribution of the securities being offered will be included in the applicable prospectus supplement. |
Item 15. | Indemnification of Directors and Officers. |
• | for any breach of the director’s duty of loyalty to our company or our stockholders; |
• | for any act or omission not in good faith or that involves intentional misconduct or knowing violation of law; |
• | under Section 174 of the DGCL regarding unlawful dividends and stock purchases; or |
• | for any transaction from which the director derived an improper personal benefit. |
TABLE OF CONTENTS
Item 16. | Exhibits. |
Exhibit No. | Description | ||
1.1* | Form of Underwriting Agreement. | ||
3.1 | Second Amended and Restated Certificate of Incorporation of Turning Point Brands, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37763) filed on May 12, 2016). | ||
3.2 | Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Registrant’s Quarterly Report on Form 10-Q (File No. 001-377673) filed on October 27, 2020). | ||
4.1* | Form of Deposit Agreement. | ||
4.2* | Form of Warrant Agreement. | ||
4.3* | Form of Unit Agreement. | ||
4.4 | Form of Indenture for Debt Securities (incorporated by reference to Exhibit 4.5 to the Registrant’s Registration Statement on Form S-3 (File No. 333-274825) filed on October 2, 2023). | ||
5.1** | Opinion of Milbank LLP. | ||
23.1** | Consent of KPMG LLP. | ||
23.2** | Consent of RSM US LLP. | ||
23.3** | Consent of Milbank LLP (included in Exhibit 5.1). | ||
24.1** | Power of Attorney (included on signature page). | ||
25.1 | Statement of Eligibility of Trustee on Form T-1, as Trustee under the Indenture for Debt Securities (incorporated by reference to Exhibit 25.1 to the Registrant’s Registration Statement on Form S-3 (File No. 333-274825) filed on October 2, 2023). | ||
107** | Filing Fee Table. | ||
* | To be filed, if necessary, by amendment or as an exhibit to a report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and incorporated herein by reference. |
** | Filed herewith. |
Item 17. | Undertakings. |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(i) | to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended; |
(ii) | to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from |
TABLE OF CONTENTS
(iii) | to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
(2) | That, for the purpose of determining any liability under the Securities Act of 1933, as amended, each such post- effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | That, for the purpose of determining liability under the Securities Act of 1933, as amended, to any purchaser: |
(i) | Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
(ii) | Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933, as amended shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. |
(5) | That, for the purpose of determining liability of the registrant under the Securities Act of 1933, as amended to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
TABLE OF CONTENTS
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
(6) | The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, as amended, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934, as amended) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(7) | Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933, as amended and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, as amended and will be governed by the final adjudication of such issue. |
(8) | To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the SEC under Section 305(b)(2) of the Trust Indenture Act. |
TABLE OF CONTENTS
TURNING POINT BRANDS, INC. | ||||||
By: | /s/ David E. Glazek | |||||
David E. Glazek | ||||||
Chief Executive Officer | ||||||
Signature | Title | Date | ||||
/s/ David E. Glazek | Director, Chief Executive Officer | November 16, 2026 | ||||
David E. Glazek | ||||||
/s/ Andrew Flynn | Chief Financial Officer | November 16, 2026 | ||||
Andrew Flynn | ||||||
/s/ Brian Wigginton | Chief Accounting Officer | November 16, 2026 | ||||
Brian Wigginton | ||||||
/s/ Gregory H. A. Baxter | Director | November 16, 2026 | ||||
Gregory H. A. Baxter | ||||||
/s/ John Catsimatidis | Director | November 16, 2026 | ||||
John Catsimatidis | ||||||
/s/ H. C. Charles Diao | Director | November 16, 2026 | ||||
H. C. Charles Diao | ||||||
/s/ Ashley Davis Frushone | Director | November 16, 2026 | ||||
Ashley Davis Frushone | ||||||
/s/ Rohith Reddy | Director | November 16, 2026 | ||||
Rohith Reddy | ||||||
/s/ Kathleen Shanahan | Director | November 16, 2026 | ||||
Kathleen Shanahan | ||||||
/s/ Stephen Usher | Director | November 16, 2026 | ||||
Stephen Usher | ||||||
/s/ Lawrence S. Wexler | Director | November 16, 2026 | ||||
Lawrence S. Wexler | ||||||